In brief: Alzheimer's disease

2001-01-25T00:00:00

Three drugs for treating Alzheimer's disease - Aricept, Exelon and Reminyl - have been approved for use in the NHS by the National Institute for Clinical Excellence. But patients have to meet a number of strict criteria, including having been assessed by a specialist clinic as having a moderate or ...

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Alternatively, click here to register for free to keep reading this article and to receive our daily news alerts

to HSJ

Sign into your account here